References
  1. Crotti S, Bottino N, Spinelli E. Spontaneous breathing during veno-venous extracorporeal membrane oxygenation. J Thorac Dis 2018;10:S661-9. 10.21037/jtd.2017.10.27
  2. Chacko CJ, Goyal S, Yusuff H. Awake extracorporeal membrane oxygenation patients expanding the horizons. J Thorac Dis . 2018;10(Suppl 18):S2215‐S2216. doi:10.21037/jtd.2018.06.28
  3. Brenner B, Corbridge T, Kazzi A. Intubation and mechanical ventilation of the asthmatic patient in respiratory failure. Proc Am Thorac Soc 2009;6:371-9. 10.1513/pats.P09ST4
  4. Williams TJ, Tuxen DV, Scheinkestel CD, et al. Risk factors for morbidity in mechanically ventilated patients with acute severe asthma. Am Rev Respir Dis 1992;146:607-15. 10.1164/ajrccm/146.3.607
  5. Banfi C, Pozzi M, Siegenthaler N, et al. Veno-venous extracorporeal membrane oxygenation: cannulation techniques. J Thorac Dis . 2016;8(12):3762‐3773. doi:10.21037/jtd.2016.12.88
  6. Cho HJ, Kim DW, Kim GS, Jeong IS. Anticoagulation Therapy during Extracorporeal Membrane Oxygenator Support in Pediatric Patients. Chonnam Med J . 2017;53(2):110‐117. doi:10.4068/cmj.2017.53.2.110
  7. Chlebowski, M.M., Baltagi, S., Carlson, M. et al.  Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO. Crit Care  24 19 (2020). https://doi.org/10.1186/s13054-020-2726-9
  8. Shoeb M, Fang MC. Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis . 2013;35(3):312‐319. doi:10.1007/s11239-013-0899-7
  9. Dang TO, Ogunniyi A, Barbee MS, Drilon A. Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancer. Expert Rev Anticancer Ther . 2016;16(1):13‐20. doi:10.1586/14737140.2016.1123626
  10. Bowman JD. The Evolving Role of PD-L1 Testing in Immunotherapy of Metastatic Melanoma and Non-Small Cell Lung Cancer. OBR Green . December 2015 Edition Vol.11, Issue 12.